Program Schedule

Clinical Practice Issues

Friday, October 10, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Health care workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, HIV-STD-TB, Investigative ID, Pediatric ID

Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans
Christine Ruh, Pharm.D. ; Ganapathi Parameswaran ; Amy Wojciechowski, Pharm.D., BCPS ; Kari Mergenhagen, Pharm.D., BCPS AQ-ID
  • IDSA poster-1 PDF.pdf (425.9 kB)
  • 740
    Hospital Avoidance Utilizing an ID Supervised OPAT Program
    Nathan Skorodin, PharmD ; Russell Petrak, MD, FIDSA ; David W. Hines, MD ; Robert Fliegelman, DO
  • 740_IDWPOSTER.pdf (694.1 kB)
  • 741
    Management of Hepatitis C Among Infectious Diseases Physicians: Current Practice and Opinions
    Cody Chastain, MD ; Susan E. Beekmann, RN, MPH ; Erika Wallender, MD, MPH ; Todd Hulgan, MD, MPH ; Jack Stapleton, MD ; Philip M. Polgreen, MD
    Evaluation of Anti-Tuberculosis Medication Errors at an Urban University Hospital
    Patrick Buczynski, MD ; Celestine Odenigbo, MD ; Jason Zucker, MD ; Shin-Pung Jen, PharmD ; David Cennimo, MD ; Amee Patrawalla, MD
    Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics
    Kimberly Blumenthal, M.D. ; Ilan Youngster, M.D. ; Robert Parker, Sc.D. ; Rochelle Walensky, MD, MPH, FIDSA ; Sandra Nelson, MD
    Tolerability of Cephalosporins and Carbapenems in Patients with Reported Penicillin Allergies in a Real World Setting
    Heather Hansen, Pharm.D. ; Mandelin Cooper, Pharm.D ; Sarah Fogg, Pharm.D ; Rosalee Zackula, MA
  • 746_IDWPOSTER_Hansen.pdf (418.0 kB)
  • 747
    Implementation of weight-based blood culture collection in pediatric hematology/oncology patients
    Martina I. Lefterova, MD, PhD ; Jennifer I. Romero ; Kathleen Gutierrez, MD ; Gary V. Dahl ; Niaz Banaei, MD
  • Lefterova-IDSA-2014.pdf (356.9 kB)
  • 748
    Outpatient Parenteral Antimicrobial Therapy (OPAT) with Continuous Infusions by Elastomeric Infusion Devices in Japan, as an Effective Tool for Better Antimicrobial Stewardship
    Ryota Hase, MD ; Naoto Hosokawa, MD, PhD ; Kiyoharu Muranaka, MD ; Daisuke Suzuki, MD ; Takahiro Mikawa, MD ; Shunsuke Uno, MD ; Kazuyasu Miyoshi, MD ; Koji Fujita, MD ; Hiroyuki Suzuki, MD
  • ID_week_poster_2014_10.3.pdf (6.1 MB)
  • 749
    Validation of the Problem List for Real-Time Identification of Patients with Pneumonia for Stewardship Intervention
    Courtney Hebert, MD, MS ; Richard King ; John Langhenry ; Benjamin Romer ; Jessica Johnston, MS ; Kurt Stevenson, MD, MPH
    Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy
    Kevin Afra, MD ; Maggie Wong, PharmD ; Michael G. Chapman, MD ; Yazdan Mirzanejad, MD ; Gregory D. Deans, MD, MHSc
  • IDWeek Poster - v4.0 FINAL.pdf (678.5 kB)
  • 751
    Outpatient Parenteral Antimicrobial Therapy (OPAT) Outcomes at a Tertiary Care Hospital
    Nabin Shrestha, MD, MPH, FIDSA ; Jugnu Shrestha ; Angela Everett ; Don Carroll ; Steven Gordon, MD, FIDSA, FSHEA ; Susan J. Rehm, MD
  • opat_outcomes.pdf (113.9 kB)
  • 752
    Assessment of Aminoglycoside Dosing at a Large Academic Medical Center
    Riane Ghamrawi, Pharm.D. ; Seth Bauer, Pharm.D. ; Jennifer Sekeres, Pharm.D. ; Elizabeth Neuner, Pharm.D. ; Andrea Pallotta, Pharm.D. ; Nabin Shrestha, MD, MPH, FIDSA
    Improving antibiotic delivery in the ICU
    Seetha Lakshmi, MD ; Lyssette Cardona, MD
  • new IDSA template2-2.pdf (372.3 kB)
  • 755
    Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs. Traditional Home Health Care (HHC)
    Richard C. Prokesch, MD, FACP, FIDSA ; John S. Adams, MD, FIDSA ; Ramesh V. Nathan, MD ; Claudia P. Schroeder, PharmD, Ph.D ; Lucinda J. Van Anglen, PharmD ; K. Dale Hooker, PharmD
    Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy (OPAT) Administered at Home
    Nabin Shrestha, MD, MPH, FIDSA ; Jugnu Shrestha ; Angela Everett ; Don Carroll ; Steven Gordon, MD, FIDSA, FSHEA ; Susan J. Rehm, MD
  • opat_ed_visits_poster.pdf (158.8 kB)
  • 757
    Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
    Amber Streifel, PharmD ; Kimberly Felder, PA-C ; Jerusha Taylor, PharmD, BCPS ; Penelope Barnes, MBBS, MRCP, FRCPATH, PhD
    Treatment Complications During Outpatient Parenteral Antimicrobial Therapy (OPAT) Administered at Home
    Nabin Shrestha, MD, MPH, FIDSA ; Jugnu Shrestha ; Angela Everett ; Don Carroll ; Steven Gordon, MD, FIDSA, FSHEA ; Susan J. Rehm, MD
  • opat_complications_poster.pdf (109.9 kB)
  • 759
    Patient-Captured Digital Images to Assess Post-operative Wounds for Infection: a pediatric ambulatory surgery cohort study
    Christina Irace, B.S. ; Heather Brouwer, B.S. ; Rachael Ross, MPH ; Matthew Miller, B.S. ; Robert Grundmeier, MD ; Susan Rettig, BSN, CIC ; Jeffrey S. Gerber, MD, PhD ; Susan E. Coffin, MD, MPH
  • CoffinPhotoPoster10032014.pdf (278.2 kB)
  • 760
    Piperacillin/Tazobactam-Induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)
    Dawood Yusef, MD ; Blanca E Gonzalez, M.D ; Charles B Foster, MD ; Johanna Goldfarb, MD ; Carla Saracusa, RN ; Sarah Worley, MS ; Camille Sabella, MD
  • Sabella-Final Poster.pdf (160.5 kB)
  • 762
    Outpatient Parenteral Antimicrobial Therapy (OPAT) Treatment Center as Part of Integrated Care Delivery Single-Center Experience from the First Three Years of Operation
    Markian Bochan, MD, PhD, FIDSA ; Anita Sung, PhD ; Deidre Elizondo, RPh ; John Lock, PharmD ; Stephen Marcella, MD ; Yang Xie, PhD, MPH
    Low Hospital Admission Rates Following Physician Office Infusion Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics (IVABs)
    Fernando S. Alvarado, MD, MPH & TM ; Brian Metzger, MD, MPH ; Richard M. Mandel, MD, FIDSA ; Richard C. Prokesch, MD, FACP, FIDSA ; Robin H. Dretler, MD, FIDSA ; H. Barry Baker, MD, FACP ; Claudia P. Schroeder, PharmD, Ph.D ; Lucinda J. Van Anglen, PharmD
    Risk Factors for Failure of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB)
    John Veillette, Pharm.D. ; Leslie Bittner, Pharm.D., BCPS ; Marion Skalweit, M.D., Ph.D. ; Usha Stiefel, M.D. ; Christopher Burant, Ph.D. ; Amy Hirsch, Pharm.D., BCPS ; Sharanie Sims, Pharm.D., BCPS (AQ-ID)
    Impact of a Hospital Based Antibiotic Stewardship Team on Prescribing Fluroquinolones at a Long Term Care Facility
    Christine Rahme, Pharm.D. ; Helen Jacoby, MD ; Karen Whalen, BSPharm, BCPS ; Lisa Avery, PharmD, BCPS

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek